Issue 5/2022
Content (11 Articles)
Diffusion tensor imaging indices as biomarkers for cognitive changes following paediatric radiotherapy: a systematic review and meta-analysis
Noor Shatirah Voon, Hanani Abdul Manan, Noorazrul Yahya
Comparison of carbon ion and photon reirradiation for recurrent glioblastoma
F. S. Lautenschlaeger, R. Dumke, M. Schymalla, H. Hauswald, B. Carl, M. Stein, U. Keber, A. Jensen, R. Engenhart-Cabillic, F. Eberle
Single-isocenter stereotactic non-coplanar arc treatment of 200 patients with brain metastases: multileaf collimator size and setup uncertainties
Lucie Calmels, Susan Blak Nyrup Biancardo, Patrik Sibolt, Susanne Nørring Bekke, Ulf Bjelkengren, Eva Wilken, Poul Geertsen, David Sjöström, Claus F. Behrens
Association between treatment-related lymphopenia and survival in glioblastoma patients following postoperative chemoradiotherapy
Roberto Mapelli, Chiara Julita, Sofia Paola Bianchi, Nicolò Gallina, Raffaella Lucchini, Martina Midulla, Flavia Puci, Jessica Saddi, Sara Trivellato, Denis Panizza, Elena De Ponti, Stefano Arcangeli
Survival outcomes, hematologic complications and growth impairment after sequential chemoradiotherapy in intracranial NGGCTs: a retrospective study
Lei Wen, Juan Li, Mingyao Lai, Zhaoming Zhou, Qingjun Hu, Guanhua Deng, Changguo Shan, Ruyu Ai, Hainan Li, Ming Lu, Liang Zhang, Taihua Wu, Dan Zhu, Yuanyuan Chen, Longhua Chen, Linbo Cai, Cheng Zhou
Chasing a rarity: a retrospective single-center evaluation of prognostic factors in primary gliosarcoma
Cas S. Dejonckheere, Alexander M. C. Böhner, David Koch, Leonard C. Schmeel, Ulrich Herrlinger, Hartmut Vatter, Matthias Schneider, Patrick Schuss, Frank A. Giordano, Mümtaz A. Köksal
Whole brain radiotherapy combined with intrathecal liposomal cytarabine for leptomeningeal metastasis—a safety analysis and validation of the EANO-ESMO classification
Sarah Iglseder, Martha Nowosielski, Gabriel Bsteh, Armin Muigg, Johanna Heugenhauser, Elke Mayer, Astrid Grams, Günther Stockhammer, Meinhard Nevinny-Stickel
Impact of prescription isodose level and collimator selection on dose homogeneity and plan quality in robotic radiosurgery
Alexandra Hellerbach, Markus Eichner, Daniel Rueß, Klaus Luyken, Mauritius Hoevels, Michael Judge, Christian Baues, Maximilian Ruge, Martin Kocher, Harald Treuer
Körperstereotaktische Bestrahlung als „Erstlinientherapie“ des oligometastasierten Nierenzellkarzinoms
Matthias Guckenberger
Deutlicher Überlebensvorteil durch simultane Radio- und Chemotherapie: Erkenntnisse aus einer chinesischen Phase-III-Studie bei älteren Patienten mit Ösophaguskarzinom
Claudia Schweizer, Rainer Fietkau, Florian Putz
Unerwünschte Ereignisse bei Patienten unter Immuntherapie nach Strahlentherapie – gepoolte Analyse von Studien aus der Datenbank der US Food and Drug Administration
Paul Griebel, Jürgen Dunst